GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $21.93 $29.93 Thursday, 18th Apr 2024 ARWR stock ended at $22.61. This is 0.355% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.97% from a day low at $21.93 to a day high of $22.80.
90 days $21.93 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2023-08-07 $31.65 $31.79 $30.72 $30.81 764 024
2023-08-04 $32.31 $32.74 $31.57 $31.65 636 112
2023-08-03 $32.85 $32.89 $32.10 $32.32 673 388
2023-08-02 $33.26 $33.59 $32.63 $32.97 876 899
2023-08-01 $34.37 $34.46 $33.52 $33.68 1 015 339
2023-07-31 $35.13 $35.69 $34.35 $34.52 593 873
2023-07-28 $36.07 $36.20 $35.02 $35.13 577 047
2023-07-27 $35.34 $36.27 $35.21 $35.83 1 316 670
2023-07-26 $35.69 $35.99 $35.05 $35.10 792 458
2023-07-25 $34.87 $35.70 $34.87 $35.62 663 354
2023-07-24 $35.99 $36.43 $34.85 $35.06 761 867
2023-07-21 $35.31 $36.12 $34.84 $36.08 872 100
2023-07-20 $34.75 $35.40 $34.51 $34.82 664 101
2023-07-19 $35.25 $35.42 $34.28 $34.57 514 561
2023-07-18 $34.70 $35.17 $34.58 $34.99 643 773
2023-07-17 $34.40 $35.70 $34.40 $34.70 1 140 892
2023-07-14 $34.60 $34.67 $34.14 $34.60 838 868
2023-07-13 $34.09 $34.77 $33.90 $34.49 617 080
2023-07-12 $34.87 $34.87 $33.82 $33.92 703 771
2023-07-11 $33.92 $34.42 $33.34 $34.29 682 442
2023-07-10 $33.10 $34.12 $32.73 $33.98 1 147 617
2023-07-07 $34.41 $34.84 $33.01 $33.32 1 259 082
2023-07-06 $34.80 $34.94 $33.84 $34.54 882 536
2023-07-05 $35.10 $35.55 $34.87 $35.15 1 408 527
2023-07-03 $35.66 $35.94 $34.91 $35.20 603 145
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT